第1期

[2006-7-22]Evaluation of clinically relevant changes in patie [2006-7-22]Defining hip pain for population studies [2006-7-22]Contribution of polymorphisms in the apolipoprotei [2006-7-22]Chondroprotective activity of N-acetylglucosamine [2006-7-22]Case number 32: Thiemann’s disease [2006-7-22]Capability for daily activities in old people with [2006-7-22]Patient centred outcomes in osteoarthritis [2006-7-22]Pain and joint mobility explain individual subdime [2006-7-22]Low density of sympathetic nerve fibres and increa [2006-7-22]Is rheumatoid arthritis disappearing? [2006-7-22]Incidence and prevalence of complaints of the neck [2006-7-22]First line treatment of knee osteoarthritis in out [2006-7-22]Up regulated expression of fractalkine/CX3CL1 and [2006-7-22]Standardised work-up programme for fever of unknow [2006-7-22]Prevalence of anti-cyclic citrullinated peptide an [2006-7-22]Prevalence and determinants of one month hand pain [2006-7-22]Prevalence and predictors of fragility fractures i [2006-7-22]When a DMARD fails, should patients switch to sulf [2006-7-22]Validation and patient acceptance of a computer to [2006-7-22]Using patients’ and rheumatologists’ opinions to s [2006-7-22]Association between baseline radiographic damage a [2006-7-22]Assessing competencies in rheumatology [2006-7-22]A multicentre, randomised, double blind, placebo c [2006-7-22]A good response to early DMARD treatment of patien